Mental health is one of the most important — and most overlooked — parts of living with lung cancer. Host James Hiter and fellow survivor Jaymie Knox have an honest conversation about the emotional toll of a stage 4 diagnosis, how to cope with scanxiety, the power of community, and why it's okay not to be okay. Jaymie shares how reframing her thinking, building a strong support network, becoming a foster mom, and leaning into purpose have helped her navigate the mental challenges of treatment. If you or someone you love is living with lung cancer, this episode is a must-listen.

Guests:

Jaymie Knox Voices of Hope Speakers Bureau Member | ALK+ Survivor & Advocate

Jaymie was diagnosed with stage 4 ALK-positive lung cancer in December 2018 at age 32 — newly married and ready to start the next chapter of her life. Her first doctor failed to stage her cancer or explain what lay ahead. She fought for better care and never looked back. Now living in Washington, D.C., Jaymie recently fulfilled a lifelong dream of becoming a foster mom to two young children. She is a passionate advocate for mental health awareness in the lung cancer community and lives by a simple philosophy: "Have your moment, then turn the page."

James Hiter Endurance Athlete | Voices of Hope Speakers Bureau Member | Survivor

James brings curiosity, determination, and hard-won wisdom to conversations about living with lung cancer. Diagnosed in 2017 with a rare multicystic presentation, he’s undergone three lung surgeries and now operates on roughly 55% of his original lung capacity—yet he still runs every single day. His journey through multidisciplinary tumor boards, second opinions, and ongoing surveillance gives him an intimate understanding of what patients and caregivers face. James asks the questions patients actually want answered because he’s wondered them himself.

Show Notes - https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-AMA-Managing-Mental-Health-Show-Notes.pdf

Transcript - https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-AMA-Mental-Health-Transcript.pdf

Watch Video - https://youtu.be/lsen2RMilEQ

LCFA Patient Education and Support

• LCFA's Patient Education Materials — Learn about types, stages, and treatment options
• The First 7 Days — LCFA's roadmap for newly diagnosed patients Biomarker Testing and Treatment Information • Biomarker Testing Resources — Why testing matters and how to get it • ALK Positive — Learn more about ALK-positive lung cancer and current treatment options Patient Communities and Support
• Elevate Lung Cancer Care – Learn about advanced ROS1+ or ALK+ non-small cell lung cancer (NSCLC) diagnosis and ways to navigate care plan discussions
• Online Biomarker-Specific Communities - additional patient-driven organizations listing
• Ask your care team about mental health support - Counseling, social work services, palliative care, and support groups at your treatment center

Screening and Early Detection

• Low-dose CT screening can reduce lung cancer mortality by 14%–25% among eligible individuals Clinical Trials • LCFA Clinical Trial Resources — Tools to find and understand clinical trial options

Subscribe to Living With Lung Cancer: Ask Me Anything podcast for future episodes on your favorite listening platform.

Join LCFA's social media communities for support and information. Facebook | Twitter | Instagram | YouTube

Lung cancer treatment takes more than physical strength — it takes time.

Host James Hiter sits down with lung cancer survivor Maida Mangiameli to talk about “time toxicity” — the often overlooked burden of treatment on daily life.

They discuss:

• What time toxicity really means for patients
• The hours spent in treatment, recovery, and waiting
• How lung cancer impacts work, routines, and independence
• The time commitment required for clinical trials
• The role caregivers play in managing that time
• How patients adjust to a new pace of life

If you or someone you love is navigating lung cancer, this episode offers a real and honest look at what treatment truly involves.

Guests: James Hiter Endurance Athlete | LCFA Speakers Bureau Member | Survivor

Diagnosed in 2017 with a rare lung cancer, James has navigated three surgeries and now operates at 55% lung capacity—yet he still runs daily. His journey through complex treatments and surveillance gives him a deep, personal understanding of the patient experience. James asks the tough questions because he’s lived them himself. Maida Mangiameli Voices of Hope Speakers Bureau Member | SCLC Survivor & Advocate

A 74-year-old survivor of extensive-stage small cell lung cancer (SCLC), Maida has been in remission for six years. From canceling a dream cruise for immediate treatment to managing spinal tumors with humor and grit, she refuses to be a statistic. Maida is a dedicated advocate for research and a powerful voice on balancing intensive medical care with a vibrant, active life. Show Notes – https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-AMA-Time-Toxicity-Show-Notes.pdf Transcript – https://lcfamerica.org/wp-content/uploads/2026/04/AMA-Time-Toxicity-Transcript.pdf Video – https://youtu.be/jgnw0B4mUZY

• NEW! LCFA Caregiver Resources Everything caregivers need in one place — guidance, community, and tools for every stage of the lung cancer journey. lcfamerica.org/living-with-lung-cancer/caregiving-resources/
• Understanding Clinical Trials: FREE Conversation Toolkit For people diagnosed with lung cancer, clinical trials may offer access to promising treatments in addition to standard care. https://lcfamerica.org/about-lung-cancer/clinical-trials/
• Side Effects & Lung Cancer: The Hidden Realities Patients Live With https://lcfamerica.org/story/side-effects-lung-cancer-the-hidden-realities-patients-live-with/

No one hands you a manual when someone you love is diagnosed with lung cancer. One day you're a daughter, a partner, a friend — and the next, you're a scheduler, an advocate, a medical translator, and an emotional anchor. And through all of it, you are still a person with your own fears, your own exhaustion, and your own life.

In this episode of Living With Lung Cancer: Ask Me Anything, host Annabelle Gurwitch sits down with actor and writer Anna Konkle for one of the most honest conversations about caregiving we've had on this podcast. Anna cared for her father through his lung cancer diagnosis and death — and she doesn't hold back about what that experience was really like.

They talk about:

• The loneliness caregivers rarely admit to
• Conflict, resentment, and the feelings no one gives you permission to have
• Respecting a loved one's autonomy while still advocating for their care
• Building a support system when you feel like you're doing it alone
• Why humor and heartbreak so often arrive together
• The unexpected healing that can happen in the hardest moments

If you're caregiving for someone with lung cancer — or you love someone who is — this episode is for you.

For caregiver resources and community support, visit lcfamerica.org.

Show Notes - https://lcfamerica.org/wp-content/uploads/2026/03/LCFA-AMA-Reality-of-Caregiving-Show-Notes.pdf Transcript - https://lcfamerica.org/wp-content/uploads/2026/03/LCFA-AMA-Reality-of-Caregiving-Transcript.pdf Video - https://youtu.be/1YBymTFk6lo

Subscribe to the Living With Lung Cancer: Ask Me Anything podcast for future episodes on your favorite listening platform.

Apple Podcasts | Spotify | Amazon Music | iHeart

Join LCFA's social media communities for support and information. Facebook | Twitter/X | Instagram | YouTube

What if treating early-stage lung cancer could be as simple as lying still for 10 minutes—no surgery, no anesthesia, no hospital stay? In this episode, host James Hiter talks with Dr. Drew Moghanaki, Chief of Thoracic Oncology at UCLA, about SABR (stereotactic ablative radiation)—a game-changing treatment that delivers highly precise radiation in just 1-5 sessions. Learn why every patient should ask for a radiation oncologist consult, how SABR compares to surgery, and why preserving lung tissue matters for long-term quality of life.

Key topics covered:

• What SABR/SBRT is and how it works
• Why treatment takes 5 sessions or less (sometimes just one!)
• The importance of biomarker testing before any local therapy
• How multidisciplinary teams improve treatment decisions
• What the treatment experience is actually like
• The future of lung cancer local therapies

Whether you're newly diagnosed with early-stage lung cancer or exploring treatment options, this conversation delivers practical information and hope through scientific progress.

Show Notes - https://lcfamerica.org/wp-content/uploads/2025/12/AMA-SABR-for-Lung-Cancer-Show-Notes.pdf Transcript - https://lcfamerica.org/wp-content/uploads/2025/12/AMA-SABR-for-Lung-Cancer-Transcript.pdf Video - https://youtu.be/a6q2ZaJp9BQ

Changing doctors can feel overwhelming, but it’s often an important part of getting the right care—especially in lung cancer. In this episode of Living With Lung Cancer: Ask Me Anything, host Annabelle Gurwitch talks with advocate Colette Smith about how to communicate your needs, recognize when a doctor isn’t the right fit, and build a care team that supports your goals. Learn practical strategies for speaking up, seeking second opinions, preparing for appointments, and staying informed about the science behind your mutation.

Show Notes - https://lcfamerica.org/wp-content/uploads/2025/12/AMA-Communicating-With-Your-Doctor-Show-Notes.pdf

Transcript - https://lcfamerica.org/wp-content/uploads/2025/12/AMA-Communicating-With-Your-Doctor-Transcript.pdf

Watch Video - https://youtu.be/pv6cQGo4gog

Communication with your oncologist can make all the difference in your lung cancer journey. In this episode, host Annabelle Gurwitch talks with thoracic oncologist Dr. Alice Shaw about how to have more effective conversations with your care team. Learn practical strategies for discussing treatment goals, managing side effects, understanding biomarker testing, and knowing when to seek a second opinion. Whether you're newly diagnosed or years into treatment, this episode offers valuable insights for becoming a more empowered patient.

Guest: Dr. Alice Shaw, Director of the Center for Thoracic Cancers at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School

Host: Annabelle Gurwitch, New York Times bestselling author, LCFA Speakers Bureau member, and lung cancer survivor

Visit her website: annabellegurwitch.com | Follow her on Facebook

Show Notes - https://lcfamerica.org/wp-content/uploads/2025/12/AMASharedDecisionMakinginLungCancerCare-Show-Notes.pdf

Transcript- https://lcfamerica.org/wp-content/uploads/2025/12/AMAShared-Decision-Making-in-Lung-Cancer-Transcript.pdf

Watch Video - https://youtu.be/BV98OiryMe0

In this episode of Living With Lung Cancer: Ask Me Anything, host Annabelle Gurwitch sits down with Dr. Alice Shaw from Dana-Farber Cancer Institute for an in-depth conversation about ROS1-positive lung cancer. Learn about this rare biomarker affecting only 1-2% of lung cancer patients, breakthrough targeted therapies, and how next-generation treatments are transforming outcomes.

Dr. Shaw, an internationally recognized expert in targeted therapies, discusses the importance of biomarker testing, clinical trial participation, and why specialized care matters for rare biomarkers. She explains how next-generation ROS1 inhibitors are more potent, selective, and designed to penetrate the brain—addressing one of lung cancer's most challenging complications.

Whether you're newly diagnosed with ROS1-positive lung cancer, a caregiver, or seeking to understand treatment advances, this episode provides essential information and real hope through scientific advancement.

Topics covered:

• What "oncogene-driven" lung cancer means and why it's good news • The critical importance of comprehensive biomarker testing • Tissue vs. liquid biopsy: which test and when • How ROS1 targeted therapies have evolved over 15 years • Next-generation treatments with better efficacy and fewer side effects • Brain penetration and preventing metastases • How to participate in clinical trials while keeping your local care team • Advocating for specialized care and second opinions • Resources for ROS1 patients and caregivers

Guest: Dr. Alice Shaw, Director of the Center for Thoracic Cancers at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School

Host: Annabelle Gurwitch, New York Times bestselling author, LCFA Speakers Bureau member, and lung cancer survivor

Show Notes - https://lcfamerica.org/wp-content/uploads/2025/11/AMA-ROS1-Positive-Lung-Cancer-Show-Notes.pdf

Transcript - https://lcfamerica.org/wp-content/uploads/2025/11/AMA-ROS1-Treatments-w-Dr-Alice-Shaw-Transcript.pdf

Watch Video - https://youtu.be/uy0B67AyyVs

Side effects can be painful, frustrating, and deeply misunderstood—especially when they’re invisible. In this episode, host Annabelle Gurwitch and advocate Colette Smith share candid stories about surgery recovery, TKI toxicity, anxiety, and the everyday challenges patients rarely talk about.

Learn how to navigate tough conversations with doctors, what to do when side effects interrupt your life, and why community support is essential. Whether you're newly diagnosed, in long-term survivorship, or supporting someone you love, this episode offers practical insight, validation, and hope.

Annabelle Gurwitch – Host, Author, and Patient Advocate Annabelle brings compassion and candor to conversations about lung cancer, creating space for honest discussions about challenges patients face—from medical debt to emotional strain.

Visit her website: annabellegurwitch.com | Follow her on Facebook

Colette Smith – Colette Smith is a dynamic lung cancer survivor, patient advocate, and community health champion who transformed her 2015 Stage 1A adenocarcinoma diagnosis into a powerful platform for change. As a never-smoker diagnosed through persistent self-advocacy, Colette's mission is to emphasize the importance of patient empowerment and early detection.

Show Notes - https://lcfamerica.org/wp-content/uploads/2025/11/AMA-Side-Effects-Show-Notes.pdf

Transcript - https://lcfamerica.org/wp-content/uploads/2025/11/AMA-Side-Effects-Transcript.pdf

Watch Video- https://youtu.be/n1_IQF3ho7Y